Expression of P-glycoprotein-mediated Drug Resistance in CHO Cells Surviving a Single X-ray Dose of 30 Gy

References

• Batist G., Tulpule A., Sinha B.K., Katki A.G., Meyers C.E., Cowan K.H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. Journal of Biological Chemistry 1986; 261: 15544–15549
   PubMed Web of Science ®Google Scholar
• Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Analytical Biochemistry 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Church G.M., Gilbert W. Genomic sequencing. Proceedings of the National Academy of Science, USA 1984; 81: 1991–1995
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C., O'Brien J.P. The multidrug resistance phenotype in human cancer. Important Advances in Oncology, V.T. De Vita, S. Hellman, S.A. Rosenberg. J. B. Lippincott Co., Philadelphia 1991; 19–38, In
   Google Scholar
• Dempke W.C.M., Whelan R.D.H., Hill B.T. Expression of resistance to etoposide and vincristine in vitro and in vivo after X-irradiation of ovarian tumour cells. Anti-Cancer Drugs 1992; 3: 395–399
   PubMed Web of Science ®Google Scholar
• Efferth T., Lohrke H., Volm M. Reciprocal correlation between expression of Pgp and accumulation of Rhodamine 123 in human tumours. Anticancer Research 1989; 9: 1633–1638
   PubMed Web of Science ®Google Scholar
• Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annual Review of Biochemistry 1989; 58: 137–171
   PubMed Web of Science ®Google Scholar
• Gros P., Shustik C. Multidrug resistance: a novel class of membrane-associated transport proteins is identified. Cancer Investigations 1991; 9: 563–569
   PubMed Web of Science ®Google Scholar
• Gunning P., Ponte P., Okayama H., Engel J., Blau H., Kedes I. Isolation and characterization of full-length cDNA clones for human alpha-, beta- and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Molecular and Cellular Biology 1983; 3: 787–795
   PubMed Web of Science ®Google Scholar
• Habig W.H., Jackoby W.B. Assays for differentiation of glutathione S-transferases. Methods in Enzymology 1981; 77: 398–405
   PubMedGoogle Scholar
• Hallahan D.E., Spriggs D.R., Beckett M.E., Kufe D.W., Weichselbaum R.R. Increased tumour necrosis factor mRNA after cellular exposure to ionizing radiation. Proceedings of the National Academy of Science, USA 1989; 86: 10104–10107
   PubMed Web of Science ®Google Scholar
• Hill B.T. Interactions between antitumour agents and radiation and the expression of resistance. Cancer Treatment Reviews 1991; 18: 149–190
   PubMed Web of Science ®Google Scholar
• Hill B.T., Bellamy A.S. Establishment of an etoposide-resistant human epithelial tumour cell line in vitro: characterisation of patterns of cross-resistance and drug sensitivities. International Journal of Cancer 1984; 33: 599–608
   PubMed Web of Science ®Google Scholar
• Hill B.T., Deuchars K., Hosking L.K., Ling V., Whelan R.D.H. Overexpression of P-glycoprotein in mammalian tumour cell lines after fractionated X-irradiation in vitro. Journal of the National Cancer Institute 1990; 82: 607–612
   PubMed Web of Science ®Google Scholar
• Hill B.T., Whelan R.D.H., Hosking L.K., Shellard S.A., Bedford P., Lock R.B. Interactions between antitumor drugs and radiation in mammalian tumor cell lines: differential drug responses and mechanisms of resistance following fractionated X-irradiation or continous drug exposure in vitro. National Cancer Institute Monographs 1988; 6: 177–181
   Google Scholar
• Hofmann J., Wolf A., Spitaler M., Bock G., Drach J., Ludescher C., Grunicke H. Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine. Journal of Cancer Research and Clinical Oncology 1992; 118: 361–366
   PubMed Web of Science ®Google Scholar
• Horio M., Gottesman M.M., Pastan I. ATP-dependent transport of VBL in vesicles from human multidrug-resistant cells. Proceedings of the National Academy of Science, USA 1988; 85: 3580–3584
   PubMed Web of Science ®Google Scholar
• Kartner N., Everden-Porelle D., Bradley G., Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 1985; 316: 820–823
   PubMed Web of Science ®Google Scholar
• Ling V., Thompson L.H. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. Journal of Cellular Physiology 1974; 83: 103–116
   PubMed Web of Science ®Google Scholar
• Lock R.B., Hill B.T. Differential patterns of anti-tumour drug responses and mechanisms of resistance in a series of independently-derived VP-16-resistant human tumour cell lines. International Journal of Cancer 1988; 42: 373–381
   PubMed Web of Science ®Google Scholar
• Mattern J., Efferth T., Volm M. Overexpression of P-glycoprotein in human lung carcinoma xenografts after fractionated irradiation in vivo. Radiation Research 1991; 127: 335–338
   PubMed Web of Science ®Google Scholar
• McClean S., Dempke W.C.M., Whelan R.D.H., Hosking L.K., Hill B.T. Overexpression of P-glycoprotein in human ovarian carcinoma cells following exposure to fractionated X-irradiation in vitro. Proceedings of the American Association for Cancer Research 1992a; 33: 470–470
   Google Scholar
• McClean S., Hosking L.K., Hill B.T. Dominant expression of drug resistance following in vitro X-irradiation exposure in intraspecific Chinese hamster ovary hybrids. Journal of the National Cancer Institute 1992b; 85: 48–53
   Google Scholar
• Nakagawa K., Saijo N., Tsuchida S., Sakai M., Tsunokawa Y., Yokota J., Muramatsu M., Sato K., Terada M., Tew K.D. Glutathione S-transferase pi as a determinant of drug resistance in transfectant cell lines. Journal of Biological Chemistry 1990; 265: 4296–4301
   PubMed Web of Science ®Google Scholar
• Neyfakh A.A. Use of fluorescent dyes and molecular probes for the study of multidrug resistance. Experimental Cell Research 1988; 174: 168–176
   PubMed Web of Science ®Google Scholar
• Riordan J.R., Deuchars K., Kartner N., Alon N., Trent J., Ling V. Amplification of P-glycoprotein genes in multi-drug resistant mammalian cell lines. Nature 1985; 316: 817–819
   PubMed Web of Science ®Google Scholar
• Schinkel A.H., Borst P. Multidrug resistance mediated by P-glycoproteins. Seminars in Cancer Biology 1991; 2: 213–226
   PubMedGoogle Scholar
• Sherman M.L., Datta R., Hallahan D., Weichselbaum R., Kufe D.W. Ionizing radiation regulates expression of the c-jun protooncogene. Proceedings of the National Academy of Science, USA 1991; 87: 5663–5666
   Web of Science ®Google Scholar
• Singh S.V., Nair S., Ahmad H., Awasthi Y., Krishan A. Glutathione S-transferases and glutathione peroxidases in doxorubucin-resistant murine leukaemic P388 cells. Biochemical Pharmacology 1989; 38: 3505–3510
   PubMed Web of Science ®Google Scholar
• Sullivan N.F., Willis A.E. Elevation of c-myc by DNA strand breakage. Oncogene 1989; 4: 1497–1502
   PubMed Web of Science ®Google Scholar
• Townsend A.J., Goldsmith M.E., Pickett C.B., Cowan K.H. Isolation, characterisation and expression of Escherichia coli of two murine μ class glutathione S-transferase cDNAs homologous to the rat subunits 3(Yb1) and 4(Yb2). Journal of Biological Chemistry 1990; 265: 21582–21590
   Google Scholar
• Townsend A.J., Tu C.-P.D., Cowan K.H. Expression of human α or μ class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents. Molecular Pharmacology 1992; 41: 230–236
   PubMed Web of Science ®Google Scholar
• Whelan R.D.H., Hosking L.K., Townsend A.J., Cowan K.H., Hill B.T. Differential increases in glutathione S-transferase activities in a range of multidrug-resistant human tumour cell lines. Cancer Communications 1990; 1: 359–365
   Google Scholar
• Yusa K., Tsuruo T. Reversal mechanism of multi-drug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Research 1989; 49: 5002–5006
   PubMed Web of Science ®Google Scholar